Global
Health
Funds
Investments to Improve and Save Lives
“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
This is my first blog post. The standard Lorem Ipsum passage, used since the 1500s “Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do
Access Bio joins Abbott as the second company with FDA authorization to distribute PCR, antigen and antibody tests for COVID-19.Access Bio joins Abbott as the
Alydia Health Completes Enrollment of its Pivotal PEARLE IDE Study in Women with Postpartum Hemorrhage The investigational Jada System is designed to treat abnormal postpartum
Milestone Reflects Merck’s Commitment to Accelerate SARS-CoV-2 Vaccine Program KENILWORTH, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the United States and Canada, today
Global Health Investment Fund Portfolio Addressing COVID-19 Pandemic The rapid spread of COVID-19 across the globe has underscored the need for an equally rapid response,
Dr. Curt LaBelle has been investing in healthcare companies for over 18 years, and now serves as the Managing Partner of the Global Health Investment Fund
Private Equity International – GHIF aims to invest $20m more in health tech by year-end, September 6, 2016 [The Global Health Investment Fund profiled, Curt LaBelle quoted]
Bloomberg Radio – The Bloomberg Advantage: LaBelle on Social Impact on Medicine, October 5, 2016 [Curt LaBelle appeared on Bloomberg Radio to discuss impact investing and GHIF]
Cheddar TV – November 11, 2016 [Curt LaBelle appeared on Cheddar TV to discuss the latest cholera vaccine news and GHIF]